Kezar Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Kezar Life Sciences

13/11/2024 14:20

* Kezar Life Sciences Inc  KZR.OQ  reported a quarterly
adjusted
loss of $2.78​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-3.20.  The mean expectation of six analysts
for the quarter was for a loss of $3.15 per share. Wall Street
expected results to range from $-3.80 to $-2.30 per share.
    * Reported revenue was zero​; analysts expected $800.00
thousand. 
    * Kezar Life Sciences Inc's reported EPS for the quarter was
a
loss of $2.78​.
    * The company reported a quarterly loss of $20.31 million.
    * Kezar Life Sciences Inc shares had fallen by 3.1% this
quarter and lost 20.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kezar Life
Sciences Inc is 19.00 
This summary was machine generated from LSEG data November 13 at
02:20 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -3.15          -2.78          Beat
 Jun. 30 2024      -3.20          -2.70          Beat
 Mar. 31 2024      -3.33          -3.00          Beat
 Dec. 31 2023      -3.80          -4.40          Missed